247 related articles for article (PubMed ID: 23199508)
1. New targets for treatment against HCV infection.
Pan Q; van der Laan LJ
Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):505-15. PubMed ID: 23199508
[TBL] [Abstract][Full Text] [Related]
2. New perspectives in HCV therapy: entry inhibitors.
Donia M; Cacopardo B; Libra M; Scalia G; McCubrey JA; Nicoletti F
Recent Pat Antiinfect Drug Discov; 2010 Nov; 5(3):181-94. PubMed ID: 20497122
[TBL] [Abstract][Full Text] [Related]
3. New insights into HCV replication: potential antiviral targets.
Rice CM
Top Antivir Med; 2011; 19(3):117-20. PubMed ID: 21946389
[TBL] [Abstract][Full Text] [Related]
4. Impact of host and virus genome variability on HCV replication and response to interferon.
Schweitzer CJ; Liang TJ
Curr Opin Virol; 2013 Oct; 3(5):501-7. PubMed ID: 23835049
[TBL] [Abstract][Full Text] [Related]
5. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
Suzuki T
Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
[TBL] [Abstract][Full Text] [Related]
6. Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics.
Guedj J; Neumann AU
J Theor Biol; 2010 Dec; 267(3):330-40. PubMed ID: 20831874
[TBL] [Abstract][Full Text] [Related]
7. [The molecular biology of hepatitis C virus].
Koutsoudakis G; Forns X; Pérez-Del-Pulgar S
Gastroenterol Hepatol; 2013 Apr; 36(4):280-93. PubMed ID: 23490024
[TBL] [Abstract][Full Text] [Related]
8. The science of direct-acting antiviral and host-targeted agent therapy.
Pawlotsky JM
Antivir Ther; 2012; 17(6 Pt B):1109-17. PubMed ID: 23188746
[TBL] [Abstract][Full Text] [Related]
9. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
[TBL] [Abstract][Full Text] [Related]
10. A preliminary analysis of hepatitis C virus in pancreatic islet cells.
Blackard JT; Kong L; Lombardi A; Homann D; Hammerstad SS; Tomer Y
Virol J; 2017 Dec; 14(1):237. PubMed ID: 29258547
[TBL] [Abstract][Full Text] [Related]
11. Targets for antiviral therapy of hepatitis C.
Rupp D; Bartenschlager R
Semin Liver Dis; 2014 Feb; 34(1):9-21. PubMed ID: 24782254
[TBL] [Abstract][Full Text] [Related]
12. Methanolic Extract of
Hung TC; Jassey A; Lin CJ; Liu CH; Lin CC; Yen MH; Lin LT
Viruses; 2018 Nov; 10(12):. PubMed ID: 30486350
[TBL] [Abstract][Full Text] [Related]
13. Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner.
Lee M; Yang J; Park S; Jo E; Kim HY; Bae YS; Windisch MP
Antiviral Res; 2016 Aug; 132():287-95. PubMed ID: 27387825
[TBL] [Abstract][Full Text] [Related]
14. Arrest all accessories--inhibition of hepatitis C virus by compounds that target host factors.
von Hahn T; Ciesek S; Manns MP
Discov Med; 2011 Sep; 12(64):237-44. PubMed ID: 21955851
[TBL] [Abstract][Full Text] [Related]
15. Procyanidin B1 purified from Cinnamomi cortex suppresses hepatitis C virus replication.
Li S; Kodama EN; Inoue Y; Tani H; Matsuura Y; Zhang J; Tanaka T; Hattori T
Antivir Chem Chemother; 2010 Aug; 20(6):239-48. PubMed ID: 20710064
[TBL] [Abstract][Full Text] [Related]
16. Curcumin against hepatitis C virus infection: spicing up antiviral therapies with 'nutraceuticals'?
Pécheur EI
Gut; 2014 Jul; 63(7):1035-7. PubMed ID: 24092864
[No Abstract] [Full Text] [Related]
17. Understanding the hepatitis C virus life cycle paves the way for highly effective therapies.
Scheel TK; Rice CM
Nat Med; 2013 Jul; 19(7):837-49. PubMed ID: 23836234
[TBL] [Abstract][Full Text] [Related]
18. [Research on hepatitis C virus entry inhibitor].
Zeng Wenting ; Lu X; Wang J; Jin X; Zhu J
Bing Du Xue Bao; 2015 Jan; 31(1):97-105. PubMed ID: 25997338
[TBL] [Abstract][Full Text] [Related]
19. Plant-derived antivirals against hepatitis c virus infection.
Jardim ACG; Shimizu JF; Rahal P; Harris M
Virol J; 2018 Feb; 15(1):34. PubMed ID: 29439720
[TBL] [Abstract][Full Text] [Related]
20. The hepatitis C virus life cycle as a target for new antiviral therapies.
Pawlotsky JM; Chevaliez S; McHutchison JG
Gastroenterology; 2007 May; 132(5):1979-98. PubMed ID: 17484890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
